Rapport Therapeutics

Third Rock’s Rapport reveals upsized $154M IPO
Fierce Biotech
Fri, 06/7/24 - 11:30 am
Rapport Therapeutics
IPOs
epilepsy
Rapport talks up $122M IPO to support proof-of-concept epilepsy trials
Fierce Biotech
Mon, 06/3/24 - 10:32 pm
Rapport Therapeutics
IPOs
epilepsy
Biopharma IPOs From the First Half of 2024
BioSpace
Thu, 05/30/24 - 11:17 am
IPOs
biotewch
CG Oncology
Kyverna Therapeutics
ArriVent Biopharma
Alto Neuroscience
Contineum Therapeutics
Boundless Bio
Fractyl Health
Metagenomi
Telomir
Rapport Therapeutics
Telix Pharmaceuticals
J&J-backed startup Rapport files for US IPO
Reuters
Sun, 05/19/24 - 10:41 pm
Rapport Therapeutics
JNJ
IPOs
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
BioSpace
Wed, 01/3/24 - 09:30 am
Rapport Therapeutics
Apogee Therapeutics
Cargo Therapeutics
Aera Therapeutics
Nido Biosciences
ReNAgade Therapeutics
Orbital Therapeutics
Abdera Therapeutics
SonoThera
Bitterroot Bio
Belharra Therapeutics
Kate Therapeutics
Convergent Therapeutics
Cajal Neuroscience
Matchpoint Therapeutics
Rapport Therapeutics brings in $150M Series B funding round
Medical Marketing and Media
Wed, 08/23/23 - 05:47 pm
Rapport Therapeutics
funding
neurological disorders
Return of the megaround: Is biotech back from the brink?
Fierce Biotech
Tue, 03/21/23 - 10:08 am
Rapport Therapeutics
Noema Pharma
Bicara Therapeutics
funding
venture capital
J&J-backed startup launches with $100M to build better brain drugs
BioPharma Dive
Tue, 03/7/23 - 11:14 am
Rapport Therapeutics
JNJ
Neuroscience
neurological disorders